A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Stephen Soltys
Advertisement
Stephen Soltys is Senior Field Application Scientist for POROS and CaptureSelect chromatography products, Bioproduction at Thermo Fisher Scientific (NC, USA).
Articles by Stephen Soltys
Advertisement
Latest Updated Articles
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
